HealthCare Innovation successfully hosted its Community Meetup 1.0, gathering a vibrant mix of experts, project managers, cluster members, junior talents, and innovators from across Tunisia’s HealthTech ecosystem. This dynamic event featured fast pitches, open Q&A sessions, idea exchanges, and informal networking over coffee and cocktails, forming a platform for accelerated collaboration and innovation.

Why This Matters

Tunisia’s HealthTech landscape thrives on ecosystem connectivity and knowledge sharing. Community Meetups facilitate direct interaction among innovators, faster validation of ideas, and strengthening of strategic partnerships essential for digital health advancement. By spotlighting startups and creating avenues for dialogue, such events foster community growth and drive tangible progress in healthcare innovation.

Event Highlights: Fast Pitches and Networking

The highlight of the hour-long Meetup was a series of lightning pitches from HealthCare Innovation’s startup studio teams, who presented:

• Key problems and innovative solutions in healthtech and digital health niches.
• Early traction signals including MVP launches, pilot programs, and partnership plans.
• Specific calls to the community for hospital and lab introductions, test user recruitment, mentor involvement, and co-development partners.

This resulted in new connections, streamlined collaboration shortcuts, and promising leads slated for follow-up the following week. The event encouraged attendees to actively share their key takeaways, further enriching the community experience. Gratitude and Next Steps A special thank you was extended to everyone who joined and supported the event, signaling enthusiastic anticipation for Community Meetup 2.0. Key contributors included:

• Dr Haroun OUANES, MBA
• Roue Bargaoui
• Abderrahmen Abdelkabir
• Nermine Dammak
• Ichraf Jarray
• Slaheddine Dardouri
• Aziz Frikha
• Mohamed Aziz ELHIF
• Imen Jani
• Lina Gargouri

HCI Resources

• Accelerating Innovation in HealthTech
• Startup Programs
• Pharma & Medical Device Regulatory Services
• Experts Network
• Community Overview

External Citations

• OECD — Digital Health Overview
• WHO — Global Strategy on Digital Health (2020–2025)

FAQ

Q: What was the format of Community Meetup 1.0? A: A highly interactive session featuring fast pitches from startups, open Q&A, idea exchanges, and informal networking to build partnerships and leads.[2] Q: Who participated and benefited from the event? A: HealthCare Innovation’s extended network including experts, project managers, startups, innovators, and junior talents across Tunisia’s HealthTech ecosystem.[2] Q: What are the expected outcomes? A: New collaborations, connections to hospitals and mentors, test user recruitment, and actionable leads for innovation follow-up. Q: How to stay engaged in the community? A: Participate in upcoming meetups and leverage HCI’s Startup Programs and expert networks for ongoing support.

L’article Our Community Meetup 1.0: Igniting Collaboration in Tunisia’s HealthTech Ecosystem est apparu en premier sur HealthCare Innovation.

Why Slush’D Algiers Matters

North Africa’s health sector is undergoing rapid transformation. By engaging in platforms such as Slush’D, Tunisia and Algeria can jointly accelerate innovation. The WHO emphasizes regional collaboration as critical for achieving sustainable health goals, while the OECD identifies cross‑border startup pipelines as essential for scaling digital health solutions.

Program Overview

• 6 high‑level inaugural talks by ministers and ambassadors.
• 10 inspiring keynote talks.
• 2 engaging panel discussions.
• A pitch competition featuring 9 promising startups.
• B2B meetings enabling collaboration and partnership opportunities.

What Participants Gained

• Exposure to Algeria’s emerging HealthTech startup ecosystem.
• Direct networking with ministers, ambassadors, and industry leaders.
• Insights from Roche and Algeria Venture on investment and acceleration.
• Opportunities for Tunisian–Algerian collaborations in HealthTech.

A Multi‑Actor Alliance for Regional Innovation

• HealthCare Innovation (HCI)
• Algeria Venture
• Roche
• Government representatives, ministers, ambassadors, and startup founders.

Strategic Impact for Tunisia & Algeria

• Strengthened synergies between Tunisia and Algeria in HealthTech innovation.
• Built connections with Algeria Venture, the country’s leading startup accelerator.
• Engaged decision‑makers to integrate HealthTech into national development agendas.
• Opened new opportunities for Euro‑Med–North Africa collaboration.

Next Steps

• Consolidate partnerships initiated during Slush’D with actionable pilot projects.
• Develop joint Tunisia‑Algeria startup acceleration programs.
• Foster cross‑border funding opportunities for HealthTech ventures.

HCI Resources 

Accelerating Innovation in HealthTech → https://healthcareinnovation.tn/accelerating-innovation-in-healthtech/
Startup Programs → https://healthcareinnovation.tn/service/startups/
Pharma & Medical Device Regulatory Services → https://healthcareinnovation.tn/service/pharma-medical-device/
Experts Network → https://healthcareinnovation.tn/experts/
Community Overview → https://healthcareinnovation.tn/community/

External Citations

WHO — Global Strategy on Digital Health (2020–2025): https://www.who.int/publications/i/item/9789240068891
OECD — Digital Health Overview: https://www.oecd.org/health/digital-health.htm
Algeria Venture — Official Site: https://algeriaventure.dz/
Roche — Official Site: https://www.roche.com/

FAQ

Q: What is Slush’D Algiers?
A: A major innovation event co‑organized by Algeria Venture and Roche, featuring talks, panels, startup pitches, and B2B meetings.
Q: Who attended from HCI?
A: Dr Haroun Ouanes, MBA, Hatem Fathallah, Ali Ayari, and Mohamed Aziz Elhif.
Q: What opportunities came from this event?
A: Strengthened Tunisia–Algeria collaborations, potential joint acceleration programs, and synergies with Algeria Venture.

L’article New Synergies at Slush’D Algiers: Boosting HealthTech in North Africa est apparu en premier sur HealthCare Innovation.

This 4-month collaboration, backed by the European Union through Euromed Clusters Forward and supported by Berytech in Lebanon, shows how Euro-Mediterranean partnerships can transform regional challenges into global opportunities.

Why This Collaboration Matters

HealthTech startups face fragmented support systems, limited funding, and complex regulatory landscapes. According to the OECD, only 10–20% of digital health ventures achieve sustainable scale.

By linking BioValley France—an established European hub for pharma, biotech, and medtech—with HealthCare Innovation (HCI)—Tunisia’s HealthTech cluster—and Berytech—a leading Lebanese entrepreneurship ecosystem—this initiative tackles those barriers head-on.

It also aligns with the WHO Global Strategy on Digital Health, which emphasizes cross-border cooperation to reduce health inequalities.

Program Overview

The 4-month collaboration sets five clear objectives:

1. Strengthen Ecosystem Synergies — Build cross-border ties between 
2. Strengthen Ecosystem Synergies — Build cross-border ties between BioValley France, HealthCare Innovation (HCI), and Berytech to connect startups, investors, and clinicians.
3. Develop a Startup Studio Model — Structure support for Tunisian entrepreneurs through HCI’s startup programs
4. Foster Pharma Open Innovation — Create co-development opportunities with pharmaceutical industries.
5. Facilitate EU Funding Access — Support startups in tapping into European grants and calls such as Horizon Europe.
6. Accelerate Market Entry — Open pathways to local and international markets, leveraging both BioValley France and Berytech networks.

Benefits for Startups & Partners

Startups and SMEs engaged in this program can:

• Join HCI’s pre-incubation and mentoring pipeline (see startup programs).
• Access pharma and medtech regulatory expertise (regulatory services).
• Tap into HCI’s expert network of clinicians and advisors (expert network).
• Become part of HCI’s community that links North Africa with Europe (community overview).
• Collaborate directly with BioValley France and Berytech to scale innovations.

Ecosystem Impact

This initiative demonstrates how clusters act as innovation bridges:

• Creating joint EU projects under Horizon Europe and beyond.
• Strengthening innovation pipelines across borders.
• Showcasing how clusters like HealthCare Innovation (HCI), BioValley France, and Berytech can act as gateways to international markets and funding.

As Berytech highlights, “ecosystem cooperation is the key to scaling local innovation to global impact.”

Internal Links Used

HealthTech transformation → https://healthcareinnovation.tn/accelerating-innovation-in-healthtech/
Startup programs → https://healthcareinnovation.tn/service/startups/
Pharma & MedTech regulatory expertise → https://healthcareinnovation.tn/service/pharma-medical-device/
Experts network → https://healthcareinnovation.tn/experts/
Community overview → https://healthcareinnovation.tn/community/

External Citations

Digital health startup survival rates — OECD (2023): https://www.oecd.org/health/digital-health.htm
Global strategy on digital health — WHO (2022): https://www.who.int/publications/i/item/9789240068891
BioValley France official website — BioValley France (2025): https://www.biovalley-france.com/
Berytech ecosystem overview — Berytech (2025): https://berytech.org/
Euromed Clusters Forward — European Cluster Collaboration Platform (2025): https://www.clustercollaboration.eu/

FAQ

Q: What is the BioValley–HCI partnership about?
A: It’s a 4-month EU-supported program connecting BioValley France, HealthCare Innovation (HCI), and Berytech to accelerate HealthTech innovation.
Q: Who are the main partners?
BioValley France, HealthCare Innovation (HCI), Berytech
Q: How does it help startups?
A: Through incubation, regulatory expertise, EU funding access, and international market entry via HCI programs, and collaboration with BioValley France and Berytech.
Q: What industries are targeted?
A: Digital health, pharmaceuticals, medtech, and biotech.
Q: How can I get involved?
A: Join HCI’s programs, connect with BioValley France, or collaborate via Berytech.

L’article BioValley & HCI Power Euro-Med HealthTech Collaboration est apparu en premier sur HealthCare Innovation.

Healthcare strategist and innovation lead working at the intersection of technology, entrepreneurship, and policy in emerging markets.

March 29th, 2025

Executive Summary: This market report examines the burgeoning HealthTech sector in North Africa, focusing on Tunisia, Morocco, and Egypt. Driven by increasing demand for accessible healthcare, this region is witnessing a surge in innovative startups leveraging AI, telemedicine, and digital solutions. This report identifies key regulatory, financial, and infrastructural challenges, while outlining actionable strategies for North Africa to emerge as a competitive hub for digital health innovation in the MENA region and beyond. By connecting innovation to institutional reform, we aim to enable the next generation of inclusive, tech-powered healthcare solutions.

Aziz.elhyf@gmail.com | Linkedin | +216 28097660

© 2025 Mohamed Aziz Elhif. All rights reserved.

1. Introduction

The HealthTech sector in North Africa is experiencing rapid growth, driven by increasing demand for accessible healthcare services, the proliferation of digital health tools, and a surge in innovative startups. Countries like Tunisia, Morocco, and Egypt are at the forefront of this transformation. This report provides an in-depth analysis of the region’s HealthTech landscape, highlights key challenges, and proposes actionable strategies to position North Africa as a global digital health innovation hub.

1. Market Landscape and Key Actors

B1. Regional Startup Ecosystem

HealthTech startups are expanding across North Africa:

• Tunisia: Home to over 90 certified HealthTech startups, Tunisia stands out as a regional leader. Companies like Cure Bionics are developing prosthetics using 3D printing and AI.
• Egypt: Startups such as Chefaa are revolutionizing e-pharmacy services by providing medication delivery and chronic disease management tools.
• Morocco: Platforms like DabaDoc are enhancing access to healthcare by connecting patients with doctors via telemedicine.

These startups are leveraging AI, logistics, and mobile health platforms to address systemic inefficiencies and improve healthcare access.

B2. Technology Trends

Emerging trends in North African HealthTech include:

• AI-driven diagnostics: Supporting faster and more accurate disease detection.
• Telemedicine: Expanding access to care in underserved rural areas.
• Interoperable Electronic Health Records (EHRs): Facilitating seamless patient data exchange.
• Mobile health platforms: Targeting rural populations with low-cost solutions.
• Digital supply chains: Streamlining pharmaceutical logistics through e-pharmacy ecosystems.

B3. Ecosystem Enablers and Partnerships

Key enablers driving growth include:

• Startup accelerators: HealthCare Innovation, Flat6Labs and Plug & Play Morocco provide funding and mentorship.
• International donors: Organizations like GIZ and USAID support capacity building.
• Local institutions: The Monastir Faculty of Medicine and Institut Pasteur foster research collaboration.

1. Strategic Challenges and Structural Barriers

C1. Regulatory Complexity

HealthTech startups face fragmented regulatory frameworks. For instance:

• In Tunisia, despite the establishment of the ANMPS (National Agency for Medicines and Health Products), there is no dedicated digital health law.
• Regulatory delays discourage private investment and slow innovation deployment.

C2. Funding and Market Readiness

HealthTech accounts for less than 5% of total VC funding in North Africa. By comparison:

• MENA-specific HealthTech VC funds have raised $0.9 billion since 2020.
• Egypt has introduced “golden licenses” to streamline approvals for qualified investors.

However, limited health-focused venture capital expertise and unproven revenue models remain barriers.

C3. Infrastructure and Workforce Limitations

Challenges include:

• Limited technological equipment in rural hospitals.
• Healthcare professionals often lack digital literacy, hindering adoption of advanced tools.

1. Strategic Recommendations

D1. National HealthTech Strategy

Governments should prioritize:

• Simplifying regulations through fast-track approval processes.
• Standardizing EHR protocols to ensure interoperability.
• Co-designing AI validation pathways with academic partners.

D2. Financing and PPP Acceleration

Adopt blended finance models combining donor funds, government grants, and private investment:

• Public-private partnerships (PPPs) with pharmaceutical companies could emulate successful collaborations like Singapore’s SingHealth initiative.

D3. Education and Capacity Building

Integrate HealthTech into medical curricula while expanding digital skills training across hospitals:

• Finland’s biomedical programs serve as a model for fostering innovation through education.

D4. Data Governance and Infrastructure Investment

Governments must modernize IT infrastructure while ensuring GDPR-aligned data governance standards to build patient trust:

• Estonia’s national health data strategy offers a blueprint for secure data sharing.

1. Foresight: 2025–2030 Outlook

By addressing these challenges, North Africa can emerge as a HealthTech leader in the MENA region by 2030 through:

• Institutionalizing AI frameworks for healthcare.
• Scaling telemedicine with reimbursement models.
• Building regional data-sharing alliances.
• Attracting international research cooperation.

L’article The Rise of HealthTech Startups in North Africa – Challenges, Opportunities, and Strategic Pathways est apparu en premier sur HealthCare Innovation.

Why the French E‑Health Ecosystem Matters

France is a leading hub for digital health innovation in Europe. The WHO Global Strategy on Digital Health underscores the importance of governance and skills, while the OECD highlights challenges in scaling digital health adoption. Learning from the French model provides insights for Tunisia and Euro‑Med ecosystems.

Program Overview

• Theme: The E‑Health ecosystem in France.
• Speakers: Dr. Sandra Chalhoub (BioValley France) & Héloïse Guillot (InSimo).
• Moderator: Sana Boujaafar.
• Date: Wednesday, March 19, 2025.
• Time: 2:00 PM – 3:30 PM CET.
• Format: Live Zoom webinar.
• Language: French.

What Participants Learned

• Insights into the structure of the French e‑health ecosystem.
• Career paths and opportunities in digital health in France.
• Practical knowledge from BioValley France and InSimo experts.
• Euro‑Med collaboration pathways for startups and students.

A Multi‑Actor Alliance Supporting Careers

The episode was organized by HealthCare Innovation (HCI), in partnership with Pharma 4 Novation, BioValley France, and InSimo.

Strategic Impact for Tunisia & Euro‑Med

• Strengthened Euro‑Med collaboration on e‑health and digital careers.
• Transfer of best practices from French innovation ecosystems to Tunisia.
• Expanded opportunities for students and professionals in digital health.
• Built bridges for Tunisian startups to access European networks.

Next Steps

Future episodes will address topics such as market access, regulatory affairs, and digital therapies, equipping youth and professionals with tools to thrive in the Euro‑Med HealthTech sector.

HCI Resources 

Accelerating Innovation in HealthTech → https://healthcareinnovation.tn/accelerating-innovation-in-healthtech/
Startup Programs → https://healthcareinnovation.tn/service/startups/
Pharma & Medical Device Regulatory Services → https://healthcareinnovation.tn/service/pharma-medical-device/
Experts Network → https://healthcareinnovation.tn/experts/
Community Overview → https://healthcareinnovation.tn/community/

External Citations

WHO — Global Strategy on Digital Health (2020–2025): https://www.who.int/publications/i/item/9789240068891
OECD — Digital Health Overview: https://www.oecd.org/health/digital-health.htm
BioValley France — Official Site: https://www.biovalley-france.com/
InSimo — Official Site: https://www.insimo.com/

FAQ

Q: Who were the guest speakers?
A: Dr. Sandra Chalhoub (BioValley France) & Héloïse Guillot (InSimo).
Q: What was the theme of Episode 2?
A: The E‑Health ecosystem in France and its career opportunities.
Q: Who organized the event?
A: HealthCare Innovation (HCI) with Pharma 4 Novation, BioValley France, and InSimo.

L’article New Careers in HealthTech: The E‑Health Ecosystem in France – Careers & Insights est apparu en premier sur HealthCare Innovation.

Why Pharma 4 Novation Matters

Pharma 4 Novation addresses systemic gaps in Tunisia’s pharmaceutical ecosystem: limited training in innovation, weak startup creation pathways, and fragmented market access. The WHO Global Strategy on Digital Health emphasizes governance and skills, while OECD digital health analyses highlight the need for structured programs that bridge academia, industry, and regulation.

Program Overview

• • • Structured pathway: idea validation → business modeling → regulatory readiness → market access.
    • 15+ projects in first edition across AI diagnostics, biotech, and digital pharmaceutical care tools.
    • Hands‑on training, expert webinars (France & Tunisia), rapid prototyping, and funding readiness.

What Participants Receive

• • • Business Design Thinking & Market Studies training.
    • Global webinars led by HCI , FPHM , and mentors from Opalia Recordati
    • Rapid prototyping workshops on AI and software integration.
    • Funding sessions delivered with Attijari bank Tunisie
    • High‑level mentoring and access to hospital/lab validation networks.

A Multi‑Actor Alliance for National Change

• • • HealthCare Innovation (HCI): Program design, expert network, strategic coordination.
    • Faculty of Pharmacy of Monastir (FPHM): Academic partner & institutional host.
    • Regional Council of Pharmacists (CNOPT): Professional oversight & field expertise.
    • Opalia Recordati: Industry partner, enabling access to real‑world challenges.

Strategic Impact for Tunisia

• • • Academic–Industry Bridging: linking training with real‑world execution.
    • Entrepreneurial Mindset: embedding innovation early in pharmacists’ careers.
    • Local Innovation, Global Vision: ensuring Euro‑Med competitiveness.
    • Sustainable Talent Pipeline: pharmacists leading in biotech, HealthTech, and entrepreneurship.

What’s Next?

Future editions will expand with broader access, more international partnerships, and deeper validation support. Pharma 4 Novation is scaling to become a flagship initiative for North Africa’s pharmaceutical and biotech sector.

HCI Resources 

Accelerating Innovation in HealthTech → https://healthcareinnovation.tn/accelerating-innovation-in-healthtech/
Startup Programs → https://healthcareinnovation.tn/service/startups/
Pharma & Medical Device Regulatory Services → https://healthcareinnovation.tn/service/pharma-medical-device/
Experts Network → https://healthcareinnovation.tn/experts/
Community Overview → https://healthcareinnovation.tn/community/

External Citations

WHO — Global Strategy on Digital Health (2020–2025): https://www.who.int/publications/i/item/9789240068891
OECD — Digital Health Overview: https://www.oecd.org/health/digital-health.htm
FPHM — Official Site: https://fphm.rnu.tn/
Opalia Recordati — Official Site: https://opaliarecordati.com/en/
CNOPT — National Order of Pharmacists: https://cnopt.tn/conseils/
Attijari bank Tunisie: https://www.attijaribank.com.tn/fr

FAQ

Q: Who can apply to Pharma 4 Novation?
A: Pharmacists and pharmacy students in Tunisia with ideas in pharma, biotech, or digital health.
Q: What support is included?
A: Training, mentoring, rapid prototyping, and funding readiness with partners like HCI, FPHM, Opalia Recordati, and Attijari bank Tunisie.
Q: How does the program ensure regulatory readiness?
A: Through EU/FDA‑aligned step‑by‑step guidance, HCI’s regulatory services, and hospital/lab validation networks.
Q: Where can I learn more?
A: Visit the official Pharma 4 Novation page or contact HCI Services

L’article Pharma 4 Novation: Empowering Tunisia’s Pharma Innovators est apparu en premier sur HealthCare Innovation.

The gathering featured international speakers and a policy discussion led by Dr. Haroun Ouanes, MBA, focused on actionable steps to scale digital health responsibly.

Who Attended

• 7 pharmaceutical laboratories
• 6 regulatory and testing institutions
• 10 academics and university representatives
• 15 experts in healthcare, investment, and market access

Policy Paper: Accelerating Digital Health

Participants discussed a strategic policy paper authored by Dr. Haroun Ouanes, MBA, identifying concrete actions for ecosystem growth—governance, validation pathways, and investment readiness—aligned with HCI’s accelerating innovation in HealthTech agenda.

Program & Partners

This meeting took place under Co‑Workup 4.0, implemented by Association Jeunes Leaders, Hive12, and HealthCare Innovation (HCI). Co‑Workup is supported by the Special Initiative “Decent Employment for a Just Transition — Invest for Jobs” from the German Federal Ministry for Economic Cooperation and Development (BMZ), implemented by GIZ Tunisie and the Tunisia Digital Transformation Center, with support from ANIMA Investment Network.

Outcomes & Next Steps

• Consolidated HCI’s position as a dynamic cluster ready to drive Tunisia’s digital health leadership.
• Onboarded new members and partners to strengthen the ecosystem’s capacity.
• Agreed to develop a pragmatic action list: governance, validation, skills, and early funding instruments.

HCI Resources 

Accelerating Innovation in HealthTech → https://healthcareinnovation.tn/accelerating-innovation-in-healthtech/
Startup Programs → https://healthcareinnovation.tn/service/startups/
Pharma & Medical Device Regulatory Services → https://healthcareinnovation.tn/service/pharma-medical-device/
Experts Network → https://healthcareinnovation.tn/experts/
Community Overview → https://healthcareinnovation.tn/community/

External References (Partners & Supporters)

Invest for Jobs — Special Initiative: https://www.invest-for-jobs.com/
BMZ — German Federal Ministry for Economic Cooperation and Development: https://www.bmz.de/en
GIZ Tunisie: https://www.giz.de/en/worldwide/335.html
Tunisia Digital Transformation Center: https://www.giz.de/en/worldwide/125208.html
ANIMA Investment Network: https://www.anima.coop/
Association Jeunes Leaders: https://www.facebook.com/AssociationJeunesLeaders/
Hive12: https://www.facebook.com/Hive12Coworking/
Co‑Workup 4.0: https://www.facebook.com/coworkup4.0/

FAQ

Q: Who took part in the event?
A: 7 pharmaceutical labs, 6 regulators/testing institutions, 10 academics, and 15 experts in healthcare, investment, and market access.
Q: What agenda items stood out?
A: A strategic policy paper on accelerating digital health, international speakers’ insights, and ecosystem commitments to validation and early funding.
Q: How can I get involved?
A: Join HCI’s Startup Programs, connect to the HCI Experts Network, and explore HCI Regulatory Services.

L’article HCI Summit: 40+ Leaders Unite for Tunisia’s Digital Health est apparu en premier sur HealthCare Innovation.

Event Overview

HCI’s Managing Director, Dr. Haroun Ouanes, met with decision‑makers, investors, and innovators to co‑design collaborations in digital health, AI, and medtech. Discussions centered on clinical validation, CE‑marking routes, and joint EU projects.

MedInTechs is a premier French HealthTech event that convenes clinicians, startups, industry, and policymakers to accelerate innovation and adoption.

Outcomes & Opportunities

• New leads for pilots and validation with French hospitals and research labs.
• Potential EU project consortia spanning France–Tunisia for digital health and connected devices.
• Investor and partner interest in Tunisia‑to‑Europe market entry strategies via HCI programs.
• Stronger visibility for HCI’s Euro‑Med HealthTech positioning.

Why It Matters

Scaling HealthTech requires evidence, partnerships, and compliant market access. The WHO Global Strategy on Digital Health underscores governance and skills, while OECD analyses point to scale‑up frictions that can be reduced through cross‑border collaboration and clear validation pathways.

Next Steps

• Formalize partnerships initiated at MedInTechs and align joint workplans for pilots.
• Map CE/FDA‑aligned validation with French and Euro‑Med clinical partners.
• Prepare proposals for EU calls with French clusters and hospitals.

HCI Resources

Accelerating Innovation in HealthTech → https://healthcareinnovation.tn/accelerating-innovation-in-healthtech/
Startup Programs → https://healthcareinnovation.tn/service/startups/
Pharma & Medical Device Regulatory Services → https://healthcareinnovation.tn/service/pharma-medical-device/
Experts Network → https://healthcareinnovation.tn/experts/
Community Overview → https://healthcareinnovation.tn/community/

External Citations

MedInTechs — Official Site: https://medintechs.com/
WHO — Global Strategy on Digital Health (2020–2025): https://www.who.int/publications/i/item/9789240068891
OECD — Digital Health Overview: https://www.oecd.org/health/digital-health.htm

FAQ

Q: What is MedInTechs?
A: A leading HealthTech event in Paris that brings together clinicians, startups, investors, and policymakers to accelerate innovation and adoption.
Q: What did HCI achieve at MedInTechs?
A: New hospital and research leads, potential EU projects with French partners, and investor interest in Euro‑Med market entry via HCI programs.
Q: Where can I get support?
A: Explore HCI’s Startup Programs, connect with the HCI Experts Network, and use HCI Regulatory Services to plan CE/FDA‑aligned validation and market entry.

L’article HCI at MedInTechs Paris: Euro‑Med HealthTech Partnerships est apparu en premier sur HealthCare Innovation.

With a strong focus on artificial intelligence (AI) in health, design thinking, and ecosystem building, the event highlighted how Euro‑Med collaboration can translate ideas into scalable innovation.

Event Overview

The ceremony opened with a contextual introduction, followed by a keynote on AI in health and practical talks on innovation, design thinking, and ecosystem leverage. The program then moved to a dynamic Q&A before the certificate awards and networking.

Highlights included:

• Keynote on AI in health by Dr. Mohamed Masmoudi (future of innovation in daily clinical practice).
• Remarks from Prof. Charfeddine Amri (Dean, FMM) on integrating the faculty with the socio‑economic fabric to benefit educators and students.
• Insights from Mrs Imen Jani (design thinking & innovation consultant) on challenging ideas and scaling to meet customer needs.
• Ecosystem perspective by Mr. Slaheddine Dardouri (management & innovation expert) on building a supportive digital health environment via EPU programs.
• Strategic outlook by Dr. Haroun Ouanes (CEO, KPI Novation) on next steps to capitalize on HCI programs and create value in HealthTech.

Outcomes: Certificates & Community

• 10 startup founders received MasterClass certificates in supporting HealthTech startups.
• 85 healthcare professionals received Level‑1 Entrepreneurship certificates from HealthCare Innovation.
• The ceremony concluded with photos and a networking cocktail to foster collaboration across clinicians, founders, and students.

Why It Matters

Workforce upskilling and structured entrepreneurship are essential to bring HealthTech to patients safely and efficiently. The WHO stresses governance and skills for digital health adoption, while the OECD notes scale‑up frictions for startups—underscoring the value of rigorous training and validation pathways.

HCI Resources 

Accelerating Innovation in HealthTech → https://healthcareinnovation.tn/accelerating-innovation-in-healthtech/
Startup Programs → https://healthcareinnovation.tn/service/startups/
Pharma & Medical Device Regulatory Services → https://healthcareinnovation.tn/service/pharma-medical-device/
Experts Network → https://healthcareinnovation.tn/experts/
Community Overview → https://healthcareinnovation.tn/community/

External Citations

WHO — Global Strategy on Digital Health (2020–2025): https://www.who.int/publications/i/item/9789240068891
OECD — Digital Health Overview: https://www.oecd.org/health/digital-health.htm

FAQ

Q: Who received certificates at the event?
A: 10 startup founders (MasterClass: Supporting HealthTech Startups) and 85 healthcare professionals (HCI Entrepreneurship Level‑1).
Q: What topics were addressed?
A: AI in health, design thinking, innovation strategy, and building a supportive digital health ecosystem.
Q: How can I benefit from similar programs?
A: Engage with HCI’s Startup Programs, connect to the HCI Experts Network, and explore HCI Regulatory Services to prepare for clinical validation and market entry.

L’article EPU6 – Celebrating HealthTech Innovators: FMM × HCI Certificates est apparu en premier sur HealthCare Innovation.

Context & Participants

Held on 2 March 2024 in the ceremonial auditorium of the Faculty of Medicine of Monastir (FMM), the session brought together 100+ clinicians, researchers, administrators, and students across Monastir, Sousse, Mahdia, and Tunis.

Why Regulation Matters for HealthTech

Predictable, risk-based regulation is essential for adoption and market access. The EU Medical Devices Regulation (MDR 2017/745) sets requirements for CE marking in Europe, while the U.S. FDA oversees market authorization in the United States. Data protection frameworks such as the GDPR govern privacy and security for digital health.

Global public-health bodies like the WHO emphasize governance, workforce skills, and interoperability as enablers of safe digital health adoption.

Key Challenges Identified

• Regulatory gap on medical devices supervision and safety; need for clearer guidance and timelines.
• High CE-marking costs that vary by device class (from tens of thousands to several hundred thousand euros).
• Limited local accreditation capacity for testing and conformity assessment, constraining time-to-market.
• Small domestic market dynamics (e.g., online payments) and capital controls deterring foreign investment inflows.
• Slow promulgation and enforcement, creating uncertainty for innovators and investors.

Pragmatic Recommendations for Tunisia

1) Start with the Target Market & Risk Class: plan the product roadmap against EU MDR and/or FDA pathways; define intended use, clinical evaluation needs, and evidence from day one.

2) Build Compliance-by-Design: align early with data protection (GDPR), cybersecurity hygiene, and quality management (e.g., ISO 13485 contexts).

3) Strengthen Local Testing & Accreditation: create or upgrade labs to support verification/validation and reduce reliance on foreign facilities.

4) Reduce Cost Barriers: deploy earmarked grants or guarantees to co-finance CE marking for startups; explore regional or pan-African schemes.

5) Enable PPP & Clearer Guidance: publish practical playbooks and timelines for pilots in hospitals, with transparent review gates.

6) Think Euro‑Med & Africa Early: design for multi-market compliance and distribution; leverage diaspora expertise and partnerships.

7) Update Legislation with a HealthTech Lens: consider dedicated taskforces and ministerial coordination to keep pace with innovation.

Best Practices & Technology Categories

• Categorize innovations by domain: HealthTech, MedTech, BioTech, and Deep Tech; tailor risk and evidence accordingly.
• Combine rapid prototyping with staged certification: prototype locally, document evidence, then seek CE/FDA while building brand and partnerships.
• Consider setting up abroad (e.g., UK/EU) for investment access while maintaining R&D roots in Tunisia.

HCI Resources 

Accelerating Innovation in HealthTech → https://healthcareinnovation.tn/accelerating-innovation-in-healthtech/
Startup Programs → https://healthcareinnovation.tn/service/startups/
Pharma & Medical Device Regulatory Services → https://healthcareinnovation.tn/service/pharma-medical-device/
Experts Network → https://healthcareinnovation.tn/experts/
Community Overview → https://healthcareinnovation.tn/community/

External Citations

EU MDR overview — European Commission: https://health.ec.europa.eu/medical-devices-regulatory-framework/overview_en
FDA medical devices — U.S. FDA: https://www.fda.gov/medical-devices
GDPR guide — GDPR.eu: https://gdpr.eu/
WHO Global Strategy on Digital Health: https://www.who.int/publications/i/item/9789240068891

FAQ

Q: What makes CE marking so expensive for startups?
A: Costs combine notified body fees, testing, documentation, and clinical evaluation—scaling with device class and complexity.
Q: How can Tunisia reduce time-to-compliance?
A: Expand accredited testing capacity, publish hospital pilot playbooks, and co-finance certification steps for early-stage innovators.
Q: Should founders wait for perfect regulations before building?
A: No—prototype and generate evidence while tracking EU/FDA pathways; iterate with hospitals and research labs, then certify.
Q: Where can I get support?
A: Engage with HCI’s Startup Programs, the HCI Experts Network, and HCI Regulatory Services.

L’article EPU5 – HealthTech Regulation in Tunisia: Insights from FMM × HCI est apparu en premier sur HealthCare Innovation.